Could a single dye replace the standard two-step test for vulvar cancer spread?
NCT ID NCT06039111
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study compares a dye called ICG alone against the standard two-method approach (ICG plus a radioactive tracer) to find cancer in lymph nodes of women with early vulvar cancer. About 58 women will take part. If ICG alone works just as well, it could simplify surgery and reduce radiation exposure.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for VULVAR CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Hamilton Health Sciences
RECRUITINGHamilton, Ontario, L8V5C2, Canada
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new drug rally the immune system against Hard-to-Treat cancers?
- New imaging tool could help surgeons detect hidden cancer cells during surgery
- New drug combo targets HPV-Driven cancers in phase II trial
- Two-Drug combo aims to shrink vulvar tumors before surgery
- New study aims to uncover why some women have worse sexual side effects from radiation
- Question list may empower gynecologic cancer patients in clinic